WEST PHARMACEUTICAL SERVICES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $28.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $28.20M, a 68.84% decline from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $90.50M, a 40.07% decline from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $151.00M, a 151.25% increase from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $60.10M, a 59.20% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2025-12-31 | $28.20M 10-K · filed 2026-02-17 |
| 2024-12-31 | $90.50M 10-K · filed 2026-02-17 |
| 2023-12-31 | $151.00M 10-K · filed 2026-02-17 |
| 2022-12-31 | $60.10M 10-K · filed 2025-02-18 |
| 2021-12-31 | $147.30M 10-K · filed 2024-02-20 |
| 2020-12-31 | $88.80M 10-K · filed 2023-02-21 |
| 2019-12-31 | $46.90M 10-K · filed 2022-02-22 |
| 2018-12-31 | $61.30M 10-K · filed 2021-02-23 |
| 2017-12-31 | $91.70M 10-K · filed 2020-02-24 |
| 2016-12-31 | $49.40M 10-K · filed 2019-02-28 |
| 2015-12-31 | $17.70M 10-K · filed 2018-02-26 |
| 2014-12-31 | $16.00M 10-K · filed 2017-02-28 |
| 2013-12-31 | $27.30M 10-K · filed 2016-02-26 |
| 2012-12-31 | $16.90M 10-K · filed 2015-02-25 |
| 2011-12-31 | $10.70M 10-K · filed 2014-02-27 |
| 2010-12-31 | $5.90M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |